This treatment defines a powerful mixture of multiple viral agents used to combat HIV infection . More precisely , it comprises bictegravir , the emtricitabine element, and tenofovir alafenamide . This core drug works by preventing the reverse transcriptase of HIV, which are essential for the HIV's ability to copy itself . Emtricitabine similarly